Related Experiment Video
Updated: Feb 22, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Midkine's Role in Cardiac Pathology
Kathleen C Woulfe1, Carmen C Sucharov1
1Department of Medicine, University of Colorado Denver, Denver, CO 80045, USA.
Abstract:
Midkine (MDK) is a heparin-binding growth factor that is normally expressed in mid-gestational development mediating mesenchymal and epithelial interactions. As organisms age, expression of MDK diminishes; however, in adults, MDK expression is associated with acute and chronic pathologic conditions such as myocardial infarction and heart failure (HF). The role of MDK is not clear in cardiovascular disease and currently there is no consensus if it plays a beneficial or detrimental role in HF. The lack of clarity in the literature is exacerbated by differing roles that circulating and myocardial MDK play in signaling pathways in cardiomyocytes (some of which have yet to be elucidated). Of particular interest, serum MDK is elevated in adults with chronic heart failure and higher circulating MDK is associated with worse cardiac function. In addition, pediatric HF patients have higher levels of myocardial MDK. This review focuses on what is known about the effect of exogenous versus myocardial MDK in various cardiac disease models in an effort to better clarify the role of midkine in HF.
Insights
Midkine (MDK) levels in heart failure (HF) are unclear. This review examines MDK
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Molecular Medicine
Background:
- Midkine (MDK) is a growth factor crucial for embryonic development.
- MDK expression decreases with age but is upregulated in adult cardiovascular diseases like heart failure (HF).
- The precise role of MDK in HF pathogenesis remains controversial, with conflicting evidence regarding its beneficial or detrimental effects.
Purpose of the Study:
- To review and clarify the dual role of Midkine (MDK) in cardiovascular disease.
- To differentiate the effects of circulating versus myocardial MDK in heart failure (HF).
- To synthesize current knowledge on exogenous and endogenous MDK in cardiac disease models.
Main Methods:
- Literature review of studies on Midkine (MDK) in cardiovascular disease models.
- Analysis of research differentiating serum MDK and myocardial MDK.
- Examination of MDK's role in both pediatric and adult heart failure (HF) contexts.
Main Results:
- Serum MDK is elevated in chronic heart failure (HF) and correlates with poorer cardiac function.
- Pediatric HF patients exhibit higher myocardial MDK levels.
- Conflicting data exists on whether MDK is protective or harmful in various HF models.
Conclusions:
- The role of Midkine (MDK) in heart failure (HF) requires further elucidation.
- Distinguishing between circulating and local MDK effects is critical for understanding HF.
- Future research should focus on clarifying MDK's specific functions in cardiac pathophysiology.
Related Concept Videos
Myocarditis I: Introduction
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification

